Access cutting-edge lung cancer treatment through this clinical trial at a research site in Bradenton. Study-provided care at no cost to qualified participants.
Access lung cancer specialists in Bradenton at no cost
This study follows strict safety protocols and ethical guidelines
All study-related lung cancer treatment provided free
Multicenter, randomized (2:1), open-label phase 3 study in HLA-A2 positive patients with squamous and non-squamous metastatic NSCLC with ICI secondary resistance. Patients will be randomized into 2 arms (randomization 2:1): experimental Arm A with OSE2101 monotherapy or control Arm B SoC with docetaxel monotherapy. Stratification factors will be histology (squamous versus non squamous) and ECOG Performance Status (0 versus 1).
Sponsor: OSE Immunotherapeutics
Check if you qualify for this lung cancer clinical trial in Bradenton, FL
If you're searching for lung cancer treatment options in Bradenton, FL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Bradenton research site is actively enrolling participants for this clinical trial. You'll receive care from experienced lung cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.